Home high-flow therapy during recovery from severe chronic obstructive pulmonary disease (COPD) exacerbation: a mixed-methods feasibility randomised control trial
Introduction Patients recovering from severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD) have a 30-day readmission rate of 20%. This study evaluated the feasibility of conducting a randomised controlled trial to evaluate clinical, patient-reported and physiological effects...
Saved in:
Main Authors: | Nicholas Hart, Louise Rose, Abdel Douiri, Georgios Kaltsakas, Eui-Sik Suh, Patrick B Murphy, Anne Rossel, Rebecca F D'Cruz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | BMJ Open Respiratory Research |
Online Access: | https://bmjopenrespres.bmj.com/content/12/1/e002698.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Wearable technology for detection of COPD exacerbations: feasibility of the Health Patch
by: Liz J.A. Cuperus, et al.
Published: (2024-11-01) -
The noninvasive ventilation outcomes score in patients requiring NIV for COPD exacerbation without prior evidence of airflow obstruction
by: Nicholas D. Lane, et al.
Published: (2024-11-01) -
Rhinovirus-Induced Exacerbations of Asthma and COPD
by: Marc B. Hershenson
Published: (2013-01-01) -
The Impact of COVID-19 on Hospitalised COPD Exacerbations in Malta
by: Yvette Farrugia, et al.
Published: (2021-01-01) -
Methods for Assessing Expiratory Flow Limitation during Tidal Breathing in COPD Patients
by: Nickolaos G. Koulouris, et al.
Published: (2012-01-01)